|
|
|
05 Jan 2007 |
AVEO acquires Clinical Stage Anti-Cancer Compound from Kirin
|
|
04 Jan 2007 |
Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
|
|
03 Jan 2007 |
Exelixis Signs Co-Development Agreement With Genentech for Small Molecule Oncology Compound
|
|
30 Dec 2006 |
Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences
|
|
29 Dec 2006 |
MedImmune In-Licenses Novel Inflammatory Disease Target
|
|
29 Dec 2006 |
Viragen Licenses Exclusive Marketing Rights for Multiferon(R) in Australia and New Zealand
|
|
28 Dec 2006 |
Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Announce Exclusive Licensing Agreement for Diabetes Compound Saxagliptin in Japan
|
|
28 Dec 2006 |
MOLOGEN AG receives upfront payment
|
|
22 Dec 2006 |
Vectura Announces Us Collaboration Agreement With Leading International Pharmaceutical Company For Combination Asthma Therapy
|
|
21 Dec 2006 |
Altus Pharmaceuticals Enters into Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Products for Growth Hormone Deficiency
|
|
21 Dec 2006 |
Kosan Announces License of Motilin Agonist Program to Pfizer
|
|
21 Dec 2006 |
CollaGenex Pharmaceuticals Signs License and Supply Agreement with MediGene for Marketing Rights to Oracea in EU and Certain Other Countries
|
|
21 Dec 2006 |
Medivir Outlicenses the Antiviral Compounds Alovudine (MIV-310) and MIV-410 to Presidio Pharmaceuticals
|
|
20 Dec 2006 |
MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With Biowa
|
|
20 Dec 2006 |
Glaxosmithkline And Genmab Enter Global Agreement For HuMax-CD20
|
|
16 Dec 2006 |
Lipoxen Announces $75M Agreement with Baxter to Develop New Blood Clotting Factors
|
|
14 Dec 2006 |
Schering-Plough Licenses Worldwide Rights to Pradefovir, Oral Hepatitis B Treatment In Development With Valeant Pharmaceuticals and Metabasis Therapeutics
|
|
13 Dec 2006 |
Schwarz Pharma transfers project rights to 4SC
|
|
13 Dec 2006 |
Abbott and Enanta Form Worldwide Alliance to Develop and Commercialize HCV Protease Inhibitors
|
|
13 Dec 2006 |
GlaxoSmithKline and EPIX Pharmaceuticals enter drug discovery and development alliance
|
|
13 Dec 2006 |
Sangamo BioSciences and City of Hope Announce License Agreement and Research Collaboration to Develop Treatment for Brain Cancer
|
|
12 Dec 2006 |
Symphogen and Meiji enter agreement
|
|
12 Dec 2006 |
Health Discovery Corporation Announces Worldwide License Agreement With Pfizer Inc.
|
|
09 Dec 2006 |
INNOVIVE Pharmaceuticals Acquires Exclusive North American Rights to Tamibarotene, a Treatment for Acute Promyelocytic Leukemia; Company to Initiate Pivotal Study in 2007
|
|
08 Dec 2006 |
Genentech and AC Immune: Exclusive License Agreement
|
|
08 Dec 2006 |
Glenmark USA signs an additional deal for 7 ANDAs with LVT
|
|
08 Dec 2006 |
Basilea to Co-Promote Ceftobiprole
|
|
08 Dec 2006 |
ThromboGenics Announces License Agreement With Bharat Biotech for Novel Thrombolytic Agent
|
|
06 Dec 2006 |
Indevus and Sanofi-Aventis' Spin-Out Company, Novexel, Announce Out-licensing of Aminocandin Anti-fungal
|
|
06 Dec 2006 |
Halozyme and Roche Enter Agreement for the Application of Enhanze, A Novel Technology to Improve Drug Delivery
|
|
05 Dec 2006 |
Wyeth Acquires Global License For Inpharmatica's Admensa Interactive
|
|
05 Dec 2006 |
AstraZeneca Licenses Rights for the Development and Commercialisation of CUBICIN(R) in China
|
|
29 Nov 2006 |
Neurogen In-licenses Drug Candidate for Parkinson's Disease and Restless Legs Syndrome
|
|
29 Nov 2006 |
Organon continues with the development of asenapine
|
|
28 Nov 2006 |
Protherics' DigiFab(TM) to replace Digitalis Antidot(R) in Europe
|
|
28 Nov 2006 |
Lundbeck And Biotie Sign Agreement For Nalmefene
|
|
28 Nov 2006 |
Biota and Boehringer Ingelheim Complete US$102 million Licence for HCV Program
|
|
25 Nov 2006 |
Biotie And Roche Sign Agreement For VAP-1 Antibody Program
|
|
23 Nov 2006 |
OctoPlus grants Green Cross Corporation exclusive Korean license to OP-145
|
|
22 Nov 2006 |
PDL BioPharma Announces Roche to Discontinue Co-Development of Daclizumab
|
|
22 Nov 2006 |
Pharmion and Nippon Shinyaku Announce Licensing Agreement for Vidaza(R) in Japan
|
|
21 Nov 2006 |
STADA reorganizes Biosimilar project Epo-zeta distribution rights to Hospira
|
|
21 Nov 2006 |
Genmab Licenses MIF Receptor Target From Cytokine Pharmasciences
|
|
16 Nov 2006 |
Pharmion Acquires Cabrellis Pharmaceuticals, Gains Rights to Amrubicin for North America and the European Union
|
|
08 Nov 2006 |
Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
|
|
08 Nov 2006 |
Senetek PLC Acquires Rights to Anticancer Technology for the Treatment of Brain Tumors Using Interference RNA
|
|
07 Nov 2006 |
Raptor Pharmaceutical Inc. Announces An Exclusive Worldwide License Agreement For Mesd Reagents For Treatment Of Cancer And Osteoporosis
|
|
03 Nov 2006 |
CuraGen and TopoTarget Out-License Worldwide Rights for Preclinical HDAC Inhibitor
|
|
02 Nov 2006 |
Cerexa, Inc. Expands Portfolio Of Novel Anti-Infective Therapies Through In-Licensing Agreement With Meiji Seika Kaisha, Ltd.
|
|
02 Nov 2006 |
MediciNova, Inc. Announces The Acquisition Of Two Novel Antithrombotic Agents From Meiji Seika Kaisha, Ltd.
|
| |
|
Results 451 - 500 of 814 |
